224 related articles for article (PubMed ID: 28076950)
1. Single Amino Acid Variant Profiles of Subpopulations in the MCF-7 Breast Cancer Cell Line.
Tan Z; Nie S; McDermott SP; Wicha MS; Lubman DM
J Proteome Res; 2017 Feb; 16(2):842-851. PubMed ID: 28076950
[TBL] [Abstract][Full Text] [Related]
2. Effect of curcumin on the cell surface markers CD44 and CD24 in breast cancer.
Calaf GM; Ponce-Cusi R; Abarca-Quinones J
Oncol Rep; 2018 Jun; 39(6):2741-2748. PubMed ID: 29693159
[TBL] [Abstract][Full Text] [Related]
3. A quantitative proteomics analysis of MCF7 breast cancer stem and progenitor cell populations.
Nie S; McDermott SP; Deol Y; Tan Z; Wicha MS; Lubman DM
Proteomics; 2015 Nov; 15(22):3772-83. PubMed ID: 26332018
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer stem cells and intrinsic subtypes: controversies rage on.
Nakshatri H; Srour EF; Badve S
Curr Stem Cell Res Ther; 2009 Jan; 4(1):50-60. PubMed ID: 19149630
[TBL] [Abstract][Full Text] [Related]
5. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y
Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075
[TBL] [Abstract][Full Text] [Related]
7. CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma.
Hoe SLL; Tan LP; Abdul Aziz N; Liew K; Teow SY; Abdul Razak FR; Chin YM; Mohamed Shahrehan NA; Chu TL; Mohd Kornain NK; Peh SC; Koay CE; Lo KW; Ahmad M; Ng CC; Khoo AS
Sci Rep; 2017 Sep; 7(1):12372. PubMed ID: 28959019
[TBL] [Abstract][Full Text] [Related]
8. Association of CD44
Chekhun VF; Lukianova NY; Chekhun SV; Bezdieniezhnykh NO; Zadvorniy TV; Borikun TV; Polishchuk LZ; Klyusov OМ
Exp Oncol; 2017 Sep; 39(3):203-211. PubMed ID: 28967645
[TBL] [Abstract][Full Text] [Related]
9. Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.
Vesuna F; Lisok A; Kimble B; Raman V
Neoplasia; 2009 Dec; 11(12):1318-28. PubMed ID: 20019840
[TBL] [Abstract][Full Text] [Related]
10. Are CD44
Ryspayeva DE; Smolanka II; Dudnichenko АS; Lyashenko AA; Grinevich YA; Gurianov VG; Koshubarova MV; Seleznev AA
Exp Oncol; 2017 Sep; 39(3):224-228. PubMed ID: 28967636
[TBL] [Abstract][Full Text] [Related]
11. CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549.
Roudi R; Madjd Z; Ebrahimi M; Samani FS; Samadikuchaksaraei A
Cell Mol Biol Lett; 2014 Mar; 19(1):23-36. PubMed ID: 24363164
[TBL] [Abstract][Full Text] [Related]
12. Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis.
Durko L; Wlodarski W; Stasikowska-Kanicka O; Wagrowska-Danilewicz M; Danilewicz M; Hogendorf P; Strzelczyk J; Malecka-Panas E
Dis Markers; 2017; 2017():3276806. PubMed ID: 28659655
[TBL] [Abstract][Full Text] [Related]
13. CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence.
Gómez-Gallegos AA; Ramírez-Vidal L; Becerril-Rico J; Pérez-Islas E; Hernandez-Peralta ZJ; Toledo-Guzmán ME; García-Carrancá A; Langley E; Hernández-Guerrero A; López-Casillas F; Herrera-Goepfert R; Oñate-Ocaña LF; Ortiz-Sánchez E
Stem Cell Res Ther; 2023 Feb; 14(1):16. PubMed ID: 36737794
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer.
Tsang JY; Huang YH; Luo MH; Ni YB; Chan SK; Lui PC; Yu AM; Tan PH; Tse GM
Breast Cancer Res Treat; 2012 Nov; 136(2):407-17. PubMed ID: 23053657
[TBL] [Abstract][Full Text] [Related]
15. Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.
Weitzenfeld P; Meshel T; Ben-Baruch A
Oncotarget; 2016 Dec; 7(49):81123-81143. PubMed ID: 27835603
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumour effects of a dual cancer-specific oncolytic adenovirus on Breast Cancer Stem cells.
Li W; Li Y; Cui Y; Li S; Zhu Y; Shang C; Song G; Liu Z; Xiu Z; Cong J; Li T; Li X; Sun L; Jin N
J Cell Mol Med; 2021 Jan; 25(2):666-676. PubMed ID: 33305893
[TBL] [Abstract][Full Text] [Related]
17. Novel triple‑positive markers identified in human non‑small cell lung cancer cell line with chemotherapy-resistant and putative cancer stem cell characteristics.
Satar NA; Fakiruddin KS; Lim MN; Mok PL; Zakaria N; Fakharuzi NA; Abd Rahman AZ; Zakaria Z; Yahaya BH; Baharuddin P
Oncol Rep; 2018 Aug; 40(2):669-681. PubMed ID: 29845263
[TBL] [Abstract][Full Text] [Related]
18. Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers.
Ghebeh H; Sleiman GM; Manogaran PS; Al-Mazrou A; Barhoush E; Al-Mohanna FH; Tulbah A; Al-Faqeeh K; Adra CN
BMC Cancer; 2013 Jun; 13():289. PubMed ID: 23768049
[TBL] [Abstract][Full Text] [Related]
19. Regulated splicing of the α6 integrin cytoplasmic domain determines the fate of breast cancer stem cells.
Goel HL; Gritsko T; Pursell B; Chang C; Shultz LD; Greiner DL; Norum JH; Toftgard R; Shaw LM; Mercurio AM
Cell Rep; 2014 May; 7(3):747-61. PubMed ID: 24767994
[TBL] [Abstract][Full Text] [Related]
20. Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity.
Jaggupilli A; Elkord E
Clin Dev Immunol; 2012; 2012():708036. PubMed ID: 22693526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
